Chapter 39 : Host Inflammatory Response to Infection

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Preview this chapter:
Zoom in

Host Inflammatory Response to Infection, Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555818005/9781555812133_Chap39-1.gif /docserver/preview/fulltext/10.1128/9781555818005/9781555812133_Chap39-2.gif


This chapter talks about some of the challenges from the various layers of the host response to which must adapt in order to survive in the gastric niche. The outcome of a persistent infection interacting with a chronic inflammatory response is discussed in the context of the survival of the organism and the impact this may have on the host. An infection introduced into the digestive tract must immediately deal with antimicrobial factors that exist in the mucous secretions of the oral cavity and stomach. The mucus overlaying the gastric epithelium provides an "antiseptic paint" containing antibodies and antimicrobial factors such as lactoferrin and lysozyme that protect mucosal tissues. Gastric antibodies may be ineffective at limiting the infection for several reasons that are more obvious when one considers how antibodies usually confer protection. Helper T-cell (Th) responses have been viewed as primarily belonging to one of two major subsets, Th1 or Th2, on the basis of their cytokine profile. The presence of an ineffective T-cell response suggests that the selection of a very limited T-cell subset facilitates persistent infection by . Th1 cells and the associated cell-mediated immunity may be tolerable when kept under control, but an overwhelming Th1 response, in combination with host genetics, specific strains of bacteria, and other environmental factors, could contribute to epithelial cell damage and ulcerogenesis. Since humans are believed to be a major reservoir for , the continued survival of the bacterial species depends largely on human-to-human transmission.

Citation: Wang J, Ernst P, Blanchard T. 2001. Host Inflammatory Response to Infection, p 471-480. In Mobley H, Mendz G, Hazell S (ed), . ASM Press, Washington, DC. doi: 10.1128/9781555818005.ch39
Highlighted Text: Show | Hide
Loading full text...

Full text loading...


Image of Figure 1
Figure 1

Helper T cell heterogeneity. One of the major immune regulatory mechanisms is the input of helper T cells. As illustrated here, various subsets of Th cells have been described on the basis of their respective cytokine panel. Thl cells are generally considered to be “proinflammatory” in the context of the digestive tract as the production of IFN-γ and TNF contributes to chronic inflammation, including gastritis associated with In contrast, Th2 cells have been described as being important for normal mucosal IgA regulation and the induction of tolerance. While Th2 cells may contribute to some inflammatory conditions and allergies, they still serve to keep Th1 responses in check. Furthermore, Th3 cells have been described as Th2 cells that produce the additional anti-inflammatory cytokine, TGF-β. Tr1 cells are yet another distinct subset of anti-inflammatory T cells and are characterized by their ability to produce high levels of IL-10 and to suppress colitis in animal models. Although the details controlling the development of these subsets are not well known, what is clear is that none of the antiinflammatory subsets are well represented in the chronically infected stomach. Thus, increasing their presence may provide the means to create protective immunity or an immunotherapy to limit the damage caused by inflammation.

Citation: Wang J, Ernst P, Blanchard T. 2001. Host Inflammatory Response to Infection, p 471-480. In Mobley H, Mendz G, Hazell S (ed), . ASM Press, Washington, DC. doi: 10.1128/9781555818005.ch39
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of Figure 2
Figure 2

Immune-mediated epithelial cell damage. This figure shows the various means by which the gastric Th1 cells may mediate epithelial cell damage. First, through the direct effect, Th1 cells can induce epithelial cell death. T-cell-derived cytokines can also increase bacterial binding and the damaging effects of infection. In addition, Th1 cells stimulate epithelial cells to produce cytokines that recruit and activate neutrophils. In turn, activated neutrophils can impart an oxidative stress that causes damage to epithelial cells as well as to cellular DNA. Finally, gastric T cells can modulate B-cell responses, possibly leading to the production of antibodies (IgG) that can activate complement (C) and contribute to immune-complex-mediated inflammation.

Citation: Wang J, Ernst P, Blanchard T. 2001. Host Inflammatory Response to Infection, p 471-480. In Mobley H, Mendz G, Hazell S (ed), . ASM Press, Washington, DC. doi: 10.1128/9781555818005.ch39
Permissions and Reprints Request Permissions
Download as Powerpoint


1. Allen, L. A.,, L. S. Schlesinger,, and B. Rang. 2000. Virulent strains of Helicobacter pylori demonstrate delayed phagocytosis and stimulate homotypic phagosome fusion in macrophages. J. Exp. Med. 191:115128.
2. Appelmelk, B. J.,, G. Faller,, D. Claeys,, T. Kirchner,, and C. M. J. E. Vandenbroucke-Grauls. 1998. Bugs on trial: the case of Helicobacter pylori and autoimmunity. Immunol. Today 19: 296299.
3. Appelmelk, B. J.,, I. Simoons-Smit,, R. Negrini,, A. P. Moran,, G. O. Aspinall,, J. G. Forte,, T. De Vries,, H. Quan,, T. Verboom,, J. J. Maaskant,, P. Ghiara,, E. J. Kuipers,, E. Bloemena,, T. M. Tadema,, R. R. Townsend,, K. Tyagarajan,, J. M. Crothers,, M. A. Monteiro,, A. Savio,, and J. De Graaf. 1996. Potential role of molecular mimicry between Helicobacter pylori lipopolysaccharide and host Lewis blood group antigens in autoimmunity. Infect. Immun. 64:20312040.
4. Bamford, K. B.,, X. J. Fan,, S. E. Crowe,, J. F. Leary,, W. K. Gourley,, G. K. Luthra,, E. G. Brooks,, D. Y. Graham,, V. E. Reyes,, and P. B. Ernst. 1998. Lymphocytes in the human gastric mucosa during Helicobacter pylori have a T helper cell 1 phenotype. Gastroenterology 114:482492.
5. Berschneider, H. M.,, and D. W. Powell. 1992. Fibroblasts modulate intestinal secretory responses to inflammatory mediators. J. Clin. Invest. 89:484489.
6. Berstad, A. E.,, P. Brandtzaeg,, R. Stave,, and T. S. Halstensen. 1997. Epithelium related deposition of activated complement in Helicobacter pylori associated gastritis. Gut 40:196203.
7. Blanchard, T. G.,, and S. J. Czinn. 1998. Review article: immunological determinants that may affect the Helicobacter pylori cancer risk. Aliment. Pharmacol. Ther. 12(Suppl. 1):8390.
8. Blanchard, T. G.,, S.J. Czinn,, J. G. Nedrud,, and R. W. Redline. 1995. Helicobacter-associated gastritis in SCID mice. Infect. Immun. 63:11131115.
9. Blanchard, T. G.,, S. J. Czinn,, R. W. Redline,, N. Sigmund,, G. Harriman,, and J. G. Nedrud. 1999. Antibody-independent protective mucosal immunity to gastric helicobacter infection in mice. Cell Immunol. 191:7480.
10. Blanchard, T. G.,, J. G. Nedrud,, and S. J. Czinn. 1999. Local and systemic antibody responses in humans with Helicobacter pylori infection. Can. J. Gastroenterol. 13:591594.
11. Blanchard, T. G.,, J. G. Nedrud,, E. S. Reardon,, and S. J. Czinn. 1999. Qualitative and quantitative analysis of the local and systemic antibody response in mice and humans with helicobacter immunity and infection. J. Infect. Dis. 179:725728.
12. Correa, P.,, and M. J. S. Miller. 1998. Carcinogenesis, apoptosis and cell proliferation. Br. Med. Bull. 54:151162.
13. Covacci, A.,, J. L. Telford,, G. Del Giudice,, J. Parsonnet,, and R. Rappuoli. 1999. Helicobacter pylori virulence and genetic geography. Science 284:13281333.
14.Crabtree.J.E. 1998. Role of cytokines in pathogenesis of Helicobacter pylori-induced mucosal damage. Dig. Dis. Sci. 43:46S55S.
15. Crabtree, J. E.,, and I. J. Lindley. 1994. Mucosal interleukin-8 and Helicobacter pylori-associated gastroduodenal disease. Eur. J. Gastroenterol. Hepatol. 6(Suppl. 1):S33S38.
16. Crabtree, J. E.,, J. I. Wyatt,, L. K. Trejdosiewicz,, P. Peichl,, P. H. Nichols,, N. Ramsay,, J. N. Primrose,, and I. J. D. Lindley. 1994. Interleukin-8 expression in Helicobacter pylori infected, normal, and neoplastic gastoduodenal mucosa. J. Clin. Pathol. 47:6166.
17. Curtis, G. H.,, and D. G. Gall. 1992. Macromolecular transport by rat gastric mucosa. Am. J. Physiol. Gastrointest. Liver Physiol. 262:G1033G1040.
18. D'Elios, M. M.,, M. Manghetti,, F. Almerigogna,, A. Amedei,, F. Costa,, D. Burroni,, C. T. Baldari,, S. Romagnani,, J. L. Telford,, and G. Del Prête. 1997. Different cytokine profile and antigen-specificity repertoire in Helicobacter pylori-specific T cell clones from the antrum of chronic gastritis patients with or without peptic ulcer. Eur. J. Immunol. 27:17511755.
19. D'Elios, M. M.,, M. Manghetti,, M. De Carli,, F. Costa,, C. T. Baldari,, D. Burroni,, J. Telford,, S. Romagnani,, and G. Del Prête. 1997. T helper 1 effector cells specific for Helicobacter pylori in gastric antrum of patients with peptic ulcer disease. J. Immunol. 158:962967.
20. Engstrand, L.,, A. Scheynius,, C. Pahlson,, L. Grimelius,, A. Schwan,, and S. Gustavsson. 1989. Association of Campylobacter pylori with induced expression of class II transplantation antigens on gastric epithelial cells. Infect. Immun. 57: 827832.
21. Ermak, T. H.,, P. J. Giannasca,, R. Nichols,, G. A. Myers,, J. Nedrud,, R. Weltzin,, C. K. Lee,, H. Kleanthous,, and T. P. Monath. 1998. Immunization of mice with urease vaccine affords protection against Helicobacter pylori infection in the absence of antibodies and is mediated by MHC class II-restricted responses. J. Exp. Med. 188:22772288.
22. Ernst, P. B.,, and B. Gold. 2000. The disease spectrum of H. pylori: the immunopathogenesis of gastroduodenal ulcer and gastric cancer. Annu. Rev. Microbiol. 54:615640.
23. Ernst, P. B.,, P. Michetti,, and P. D. Smith (ed.). 1997. The Immunobiology of Helicobacter pylori: from Pathogenesis to Prevention. Lippincott-Raven, Philadelphia, Pa.
24. Falkow, S. 1997. What is a pathogen? ASM News 63: 359365.
25. Fan, X. J.,, A. Chua,, C. N. Shahi,, J. McDevitt,, P. W. N. Keeling,, and D. Kelleher. 1994. Gastric T lymphocyte response to Helicobacter pylori in patients with H. pylori colonisation. Gut 35:13791384.
26. Fan, X. J.,, S. E. Crowe,, S. Behar,, H. Gunasena,, G. Ye,, H. Haeberle,, N. Van Houten,, W. K. Gourley,, P. B. Ernst,, and V. E. Reyes. 1998. The effect of class II MHC expression on adherence of Helicobacter pylori and induction of apoptosis in gastric epithelial cells: a mechanism for Th1 cell-mediated damage. J. Exp. Med. 187:16591669.
27. Fan, X. J.,, H. Gunasena,, K. B. Bamford,, R. Espejo,, S. E. Crowe,, P. B. Ernst,, and V. E. Reyes. 1999. Helicobacter pylori urease resembles a superantigen in its interaction with class II MHC bearing cells. J. Immunol. 165:19181924.
28. Fox, J. G.,, M. Batchelder,, A. Hayward,, L. Yan,, L. Palley,, J. C. Murphy,, and B. Shames. 1994. Prior Helicobacter mustelae infection does not confer protective immunity against experimental reinfection in ferrets. Am. J. Gastroenterol. 89: 13181322.
29. Greiner, A.,, A. Marx,, J. Heesemann,, J. Leebmann,, B. Schmausser,, and H. K. Muller-Hermelink. 1994. Idiotype identity in a MALT-type lymphoma and B cells in Helicobacter pylori associated chronic gastritis. Lab. Invest. 70:572578.
30. Groux, H.,, A. O'Garra,, M. Bigler,, M. Rouleau,, S. Antonenko,, J. E. deVries,, and M. G. Roncarolo. 1997. A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 389:737742.
31. Haeberle, H.,, M. Kubin,, K. B. Bamford,, R. Garofalo,, D. Y. Graham,, F. El-Zaateri,, R. Karttunen,, S. E. Crowe,, V. E. Reyes,, and P. B. Ernst. 1997. Induction of IL-12 and selection of Thl cells in the gastric mucosa in response to H. pylori. Infect. Immun. 65:42294235.
32. Hazell, S. L.,, A. Lee,, L. Brady,, and W. Hennessy. 1986. Campylobacter pyloridis and gastritis: association with intercellular spaces and adaption to an environment of mucus as important factors in colonization of the gastric epithelium. J. Infect. Dis. 153:658663.
33. Inobe, J.,, A. J. Slavin,, Y. Komagata,, Y. Chen,, L. Liu,, and H. L. Weiner. 1998. IL-4 is a differentiation factor for transforming growth factor-beta secreting Th3 cells and oral administration of IL-4 enhances oral tolerance in experimental allergic encephalomyelitis. Eur. J. Immunol. 28:27802790.
34. Itoh, T.,, Y. Wakatsuki,, M. Yoshida,, T. Usui,, Y. Matsunaga,, S. Kaneko,, T. Chiba,, and T. Kita. 1999. The vast majority of gastric T cells are polarized to produce T helper 1 type cytokines upon antigenic stimulation despite the absence of Helicobacter pylori infection. J. Gastroenterol. 34:560570.
35. Karttunen, R. 1991. Blood lymphocyte proliferation, cytokine secretion and appearance of T cells with activation markers in cultures with Helicobacter pylori. Comparison of the responses of subjects with and without antibodies to H. pylori. Clin. Exp. Immunol. 83:396400.
36. Karttunen, R.,, T. Karttunen,, H.-P. T. Ekre,, and T. T. Mac-Donald. 1995. Interferon gamma and interleukin 4 secreting cells in the gastric antrum in Helicobacter pylori positive and negative gastritis. Gut 36:341345.
37. Kelly, C. P.,, S. Becker,, J. K. Linevsky,, M. A. Joshi,, J. C. O'Keane,, B. F. Dickey,, J. T. LaMont,, and C. Pothoulakis. 1994. Neutrophil recruitment in Clostridium difficile toxin A enteritis in the rabbit. J. Clin. Invest. 93:12571265.
38. Kelso, A. 1995. Thl and Th2 subsets: paradigms lost? Immunol. Today 16:374379.
39. Kirchner, T.,, A. Melber,, W. Fischbach,, K. L. Heilmann,, and H. K. Muller-Hermelink,. 1990. Immunohistological patterns of the local immune response in Helicobacter pylori gastritis, p. 213222. In P. Malfertheiner, and H. Ditschuneit (ed.), Helicobacter pylori, Gastritis and Peptic Ulcer. Springer-Verlag, Berlin, Germany.
40. Klimpel, G. R.,, A. K. Chopra,, K. E. Langley,, J. Wypych,, C. A. Annable,, D. Kaiserlian,, P. B. Ernst,, and J. W. Peterson. 1995. A role for stem cell factor and c-kit in the murine intestinal tract secretory response to cholera toxin. J. Exp. Med. 182:19311942.
41. Knipp, U.,, S. Birkholz,, W. Kaup,, K. Mahnke,, and W. Opferkuch. 1994. Suppression of human mononuclear cell response by Helicobacter pylori: effects on isolated monocytes and lymphocytes. FEMS Immunol. Med. Microbiol. 8:157166.
42. Kuhn, R.,, J. Lohler,, D. Rennick,, K. Rajewsky,, and W. Muller. 1993. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75:263274.
43. Langenberg, W.,, E. A. Rauws,, J. H. Oudbier,, and G. N. Tytgat. 1990. Patient-to-patient transmission of Campylobacter pylori infection by fiberoptic gastroduodenoscopy and biopsy. J. Infect. Dis. 161:507511.
44. Lederberg, J. 1999. Paradoxes of the host-parasite relationship. ASM News 65:811816.
45. Liblau, R. S.,, S. M. Singer,, and H. O. McDevitt. 1995. Thl and Th2 CD4+ T cells in the pathogenesis of organ-specific autoimmune diseases. Immunol. Today 16:3438.
46. Madara, J. L.,, S. Nash,, and C. Parkos. 1991. Neutrophil-epithelial cell interactions in the intestine. Adv. Exp. Med. Biol. 314:329334.
47. Madara, J. L.,, T. W. Patapoff,, B. Gillece-Castro,, S. P. Colgan,, C. A. Parkos,, C. Delp,, and R. J. Mrsny. 1993. 5'-adenosine monophosphate is the neutrophil-derived paracrine factor that elicits chloride secretion from T84 intestinal epithelial cell monolayers. J. Clin. Invest. 91:23202325.
48. Madara, J. L.,, and J. Stafford. 1989. Interferon-7 directly affects barrier function of cultured intestinal epithelial monolayers. J. Clin. Invest. 83:724727.
49. Marano, B. J., Jr.,, F. Smith,, and C. A. Bonanno. 1993. Helicobacter pylori prevalence in acquired immunodeficiency syndrome. Am. J. Gastroenterol. 88:687690.
50. Mizukawa, N.,, K. Sugiyama,, T. Ueno,, K. Mishima,, S. Takagi,, and T. Sugahara. 1999. Defensin-1, an antimicrobial peptide present in the saliva of patients with oral diseases. Oral Dis. 5:139142.
51. Mobley, H. L.,, R. M. Garner,, and P. Bauerfeind. 1995. Helicobacter pylori nickel-transport gene nixA: synthesis of catalyti-cally active urease in Escherichia coli independent of growth conditions. Mol. Microbiol. 16:97109.
52. Mobley, H. L.,, M. D. Island,, and R. P. Hausinger. 1995. Molecular biology of microbial ureases. Microbiol. Rev. 59: 451480.
53. Mobley, H. L. T.,, L.-T. Hu,, and P. A. Foxall. 1991. Helicobacter pylori urease: properties and role in pathogenesis. Scand. J. Gastroenterol. 26(Suppl. 187):3946.
54. Mohammadi, M.,, J. Nedrud,, R. Redline,, N. Lycke,, and S. J. Czinn. 1997. Murine CD4 T-cell response to helicobacter infection: TH1 cells enhance gastritis and TH2 cells reduce bacterial load. Gastroenterology 113:18481857.
55. Molinari, M.,, M. Salio,, C. Galli,, N. Norais,, R. Rappuoli,, A. Lanzavecchia,, and C. Montecucco. 1998. Selective inhibition of Ii-dependent antigen presentation by Helicobacter pylori toxin VacA. Exp. Med. 187:135140.
56. Mombaerts, P.,, E. Mizoguchi,, M. J. Grusby,, L. H. Ghmcher,, A. K. Bhan,, and S. Tonegawa. 1993. Spontaneous development of inflammatory bowel disease in T cell receptor mutant mice. Cell 75:275282.
57. Moss, S. F. 1999. The carcinogenic effect of H. pylori on the gastric epithelial cell. J. Physiol. Pharmacol. 50:847856.
58. Nakajima, S.,, B. Krishnan,, H. Ota,, A. M. Segura,, T. Hattori,, D. Y. Graham,, and R. M. Genta. 1997. Mast cell involvement in gastritis with or without Helicobacter pylori infection. Gastroenterology 113:746754.
59. Nakao, K.,, I. Imoto,, E. C. Gabazza,, K. Yamauchi,, N. Yama-zaki,, Y. Taguchi,, T. Shibata,, S. Takaji,, N. Ikemura,, and M. Misaki. 1997. Gastric juice levels of lactoferrin and Helicobacter pylori infection. Scand. J. Gastroenterol. 32:530534.
60. Nakao, K.,, I. Imoto,, N. Ikemura,, T. Shibata,, S. Takaji,, Y. Taguchi,, M. Misaki,, K. Yamauchi,, and N. Yamazaki. 1997. Relation of lactoferrin levels in gastric mucosa with Helicobacter pylori infection and with the degree of gastric inflammation. Am. J. Gastroenterol. 92:10051011.
61. Negrini, R.,, L. Lisato,, I. Zanella,, L. Cavazzini,, S. Gullini,, V. Villanacci,, C. Poiesi,, A. Albertini,, and S. Ghielmi. 1991. Helicobacter pylori infection induces antibodies cross-reacting with human gastric mucosa. Gastroenterology 101:437445.
62. O'Neil, D. A.,, S. P. Cole,, E. Martin-Porter,, M. P. Housley,, L. Liu,, T. Ganz,, and M. F. Kagnoff. 2000. Regulation of human beta-defensins by gastric epithelial cells in response to infection with Helicobacter pylori or stimulation with interleukin-1. Infect. Immun. 68:54125415.
63. Peek, R. M., Jr.,, G. G. Miller,, K. T. Tham,, G. I. Perez-Perez,, X. Zhao,, J. C. Atherton,, and M. J. Blaser. 1995. Heightened inflammatory response and cytokine expression in vivo to cagA + Helicobacter pylori strains. Lab. Invest. 73:760770.
64. Powrie, F.,, and M. W. Leach. 1995. Genetic and spontaneous models of inflammatory bowel disease in rodents: evidence for abnormalities in mucosal immune regulation. Ther. Immunol. 2:115123.
65. Rath, H. C.,, H. H. Herfarth,, J. S. Ikeda,, W. B. Grenther, Jr.,, T. E. Hamm,, E. Balish,, J. D. Taurog,, R. E. Hammer,, K. H. Wilson,, and R. B. Sartor. 1996. Normal luminal bacteria, especially Bacteroides species, mediate chronic colitis, gastritis and arthritis in HLS-B27/human beta2 microglobulin transgenic rats. J. Clin. Invest. 98:945953.
66. Ridgway, W. M.,, H. L. Weiner,, and C. G. Fathman. 1994. Regulation of autoimmune response. Curr. Opin. Immunol. 6:946955.
67. Roth, K. A.,, S. B. Kapadia,, S. M. Martin,, and R. G. Lorenz. 1999. Cellular immune responses are essential for the development of Helicobacter /é/í's-associated gastric pathology. J. Immunol. 163:14901497.
68. Rudi, J.,, D. Kuck,, S. Strand,, A. Von Herbay,, S. M. Mariani,, P. H. Krammer,, P. R. Galle,, and W. Stremmel. 1998. Involvement of the CD95 (APO-1/Fas) receptor and ligand system in Helicobacter pylori-induced gastric epithelial apoptosis. J. Clin. Invest. 102:15061514.
69. Shirai, Y.,, Y. Wakatsuki,, T. Kusumoto,, M. Nakata,, M. Yos-hida,, T. Usui,, T. Iizuka,, and T. Kita. 2000. Induction and maintenance of immune effector cells in the gastric tissue of mice orally immunized to Helicobacter pylori requires salivary glands. Gastroenterology 118:749759.
70. Sommer, F.,, G. Faller,, P. Konturek,, T. Kirchner,, E. G. Harm,, J. Zeus,, M. Rollinghoff,, and M. Lohoff. 1998. Antrum- and corpus mucosa-infiltrating CD4( + ) lymphocytes in Helicobacter pylori gastritis display a Th1 phenotype. Infect. Immun. 66:55435546.
71. Spencer, S. D.,, F. Di Marco,, J. Hooley,, S. Pitts-Meek,, M. Bauer,, A. M. Ryan,, B. Sordat,, V. C. Gibbs,, and M. Aguet. 1998. The orphan receptor CRF2-4 is an essential subunit of the interleukin 10 receptor. J. Exp. Med. 187:571578.
72. Strober, W. 1985. Animal models of inflammatory bowel disease—an overview. Dig. Dis. Sci. 30:3S10S.
73. Strober, W.,, and R. O. Ehrhardt. 1993. Chronic intestinal inflammation: an unexpected outcome in cytokine or T cell receptor mutant mice. Cell 75:203205.
74. Tenovuo, J. 1998. Antimicrobial function of human saliva—how important is it for oral health? Acta Odontol. Scand. 56:250256.
75. Vaines, K.,, H. S. Huitfeldt,, and P. Brandtzaeg. 1990. Relation between T cell number and epithelial HLA class II expression quantified by image analysis in normal and inflamed human gastric mucosa. Gut 31:647652.
76. Vollmers, H. P.,, J. Dammrich,, H. Ribbert,, S. Grassel,, S. Debus,, J. Heesemannn,, and H. K. Muller-Hermelink. 1994. Human monoclonal antibodies from stomach carcinoma patients react with Helicobacter pylori and stimulate stomach cancer cells in vitro. Cancer 74:15251532.
77. von Ritter, C.,, and D. N. Granger. 1989. Neutrophilic proteases: mediators of formyl-methionyl-leucyl-phenylalanine-induced increase in mucosal permeability in rats. Gastroenterology 97:605609.
78. Wagner, S.,, W. Beil,, J. Westermann,, R. P. H. Logan,, C. T. Bock,, C. Trautwein,, J. S. Bleck,, and M. P. Manns. 1997. Regulation of epithelial cell growth by Helicobacter pylori: evidence for a major role of apoptosis. Gastroenterology 113:18361847.
79. Wang, J.,, X. J. Fan,, C. Lindholm,, M. Bennett,, J. O'Connell,, F. Shanahan,, E. G. Brooks,, V. E. Reyes,, and P. B. Ernst. 2000. Helicobacter pylori modulates lymphoepithelial cell interactions leading to epithelial cell damage through Fas/Fas ligand interactions. Infect. Immun. 68:43034311.
80. Wirth, H. P.,, M. Yang,, R. M. Peek, Jr.,, K. T. Tham,, and M. J. Blaser. 1997. Helicobacter pylori Lewis expression is related to the host Lewis phenotype. Gastroenterology 113: 10911098.
81. Wirtz, S.,, S. Finotto,, S. Kanzler,, A. W. Lohse,, M. Blessing,, H. A. Lehr,, P. R. Galle,, and M. F. Neurath. 1999. Chronic intestinal inflammation in STAT-4 transgenic mice: characterization of disease and adoptive transfer by TNF-plus IFN-gamma-producing CD4 + T cells that respond to bacterial antigens. J. Immunol. 162:18841888.
82. Wyatt, J. I.,, and B. J. Rathbone. 1988. Immune response of the gastric mucosa to Campylobacter pylori. Scand. J. Gastroenterol. 23:4449.
83. Xu-Amano, B. J.,, H. Kiyono,, R. J. Jackson,, H. F. Staats,, K. Fujihashi,, P. D. Burrows,, C. O. Elson,, S. Pillai,, and J. R. McGhee. 1993. Helper T cell subsets for immunoglobulin A responses: oral immunization with tetanus toxoid and cholera toxin as adjuvant selectively induces Th2 cells in mucosa associated tissues. J. Exp. Med. 178:13091320.
84. Yamaoka, Y.,, M. Kita,, T. Kodama,, N. Sawai,, K. Kashima,, and J. Imanishi. 1997. Induction of various cytokines and development of severe mucosal inflammation by cagA gene positive Helicobacter pylori strains. Gut 41:442451.
85. Yamaoka, Y.,, M. Kita,, N. Sawai,, and J. Imanishi. 1996. Helicobacter pylori cagA gene and expression of cytokine messenger RNA in gastric mucosa. Gastroenterology 110:17441752.
86. Yasumoto, K.,, S. Okamoto,, N. Mukaida,, S. Murakami,, M. Mai,, and K. Matsushima. 1992. Tumor necrosis factor α and interferon γ synergistically induce interleukin 8 production in a human gastric cancer cell line through acting concurrently on AP-1 and NF-kappaB-like binding sites of the interleukin 8 gene. J. Biol. Chem. 267:2250622511.


Generic image for table
Table 1

Evidence favoring a role for the host response in defining microbial pathogenesis

Citation: Wang J, Ernst P, Blanchard T. 2001. Host Inflammatory Response to Infection, p 471-480. In Mobley H, Mendz G, Hazell S (ed), . ASM Press, Washington, DC. doi: 10.1128/9781555818005.ch39

This is a required field
Please enter a valid email address
Please check the format of the address you have entered.
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error